| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |